A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-05-11) →
What happened
ImmuneOncia Therapeutics disclosed a new share issuance to raise US$81.6M, about 42.6% of its market value.
For context, this raise equals about 42.6% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Share issuance |
|---|---|
| Raise amount | US$81.6M |
| vs. market value | 42.6% |
| Filed | 2026-02-06, Material event report (rights offering) |
| Source | DART rcept 20260206002032 → open original filing |
Versions of this filing
- 2026-02-06Original (this page)
- 2026-03-04Amendment 1
- 2026-04-02Amendment 2
- 2026-05-11Amendment 3
Source: DART. Information only, not investment advice.